The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Single Molecule Real Time Sequencing Market Increase Between 2026 And 2030?
The single molecule real time sequencing market has experienced strong expansion over recent years. This market is projected to grow from $3.43 billion in 2025 to $3.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The historical increase can be attributed to advancements in DNA sequencing chemistry, the expansion of genomic research programs, a rising adoption of next-generation sequencing platforms, increased funding for genetic studies, and the growing use of long-read data in research.
The single molecule real time sequencing market is poised for robust expansion in the coming years, with projections indicating it will reach $5.15 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4%. This anticipated growth stems from an escalating demand for comprehensive genome analysis, the increasing clinical acceptance of long-read sequencing, the broadening scope of epigenetics research applications, the deeper integration of AI-driven genomic analytics, and a sustained reduction in sequencing error rates. During this forecast period, significant trends are expected to include a wider adoption of long-read sequencing technologies, a rising need for real-time DNA analysis, the growing incorporation of cloud-based bioinformatics tools, an expansion of high-accuracy genome assembly applications, and a sharpened focus on detecting structural variants.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20631&type=smp
What Major Growth Factors Are Impacting The Single Molecule Real Time Sequencing Market?
The increasing occurrence of neurological conditions is projected to boost the expansion of the single molecule real time sequencing market. Neurological diseases encompass ailments impacting the nervous system—specifically the brain, spinal cord, and peripheral nerves—resulting in various symptoms like compromised movement, sensation, thought processes, and motor skills. Examples of prevalent neurological conditions feature Alzheimer’s, Parkinson’s, stroke, epilepsy, among others. The surge in neurological disorders is linked to factors such as an aging demographic, heightened public awareness, advanced diagnostic methods, and environmental influences. Single-molecule real-time (SMRT) sequencing delivers precise genetic data essential for comprehending and managing neurological ailments. For instance, in May 2024, a report from the Alzheimer’s Association, a US-based nonprofit organization focused on Alzheimer’s support and research, indicated that the count of Americans aged 65 and older diagnosed with Alzheimer’s grew from 6.5 million in 2022 to 6.9 million in 2024. Consequently, the increasing incidence of neurological diseases is set to fuel the expansion of the single molecule real time sequencing market.
Which Segment Divisions Form The Structure Of The Single Molecule Real Time Sequencing Market?
The single molecule real time sequencing market covered in this report is segmented –
1) By Workflow Stage: Pre-Sequencing, Sequencing, Data Analysis
2) By Product: Consumable, Instrument, Services
3) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications
4) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End Users
Subsegments:
1) By Pre-Sequencing: Library Preparation Kits, DNA/RNA Extraction And Purification Products, Quality Control And Quantification Tools
2) By Sequencing: Real-Time Sequencing Systems, Portable Sequencing Devices, High-Throughput Sequencing Platforms
3) By Data Analysis: Software For Data Processing, Bioinformatics Tools, Cloud-Based Data Analysis Solutions
What Trends Are Affecting The Growth Of The Single Molecule Real Time Sequencing Market?
Major companies operating in the single-dose radiotherapy services market are intensifying their efforts on developing innovative solutions, such as radiation therapy computed tomography (CT) solutions, to enhance imaging accuracy and streamline simulation workflows for oncology care. A novel radiation therapy computed tomography (CT) solution serves as an advanced imaging system crafted to improve the precision of radiation treatment, while the AI-enhanced iteration of the intelligent radiation therapy (iRT) platform integrates artificial intelligence to optimize and individualize radiation therapy plans. For instance, in May 2024, GE HealthCare, a US-based medical technology company, launched Revolution RT and the Updated Intelligent Radiation Therapy (IRT) Platform. These solutions offer improved imaging accuracy, enhanced workflow efficiency, and AI-driven personalization, with Revolution RT focusing on precise radiotherapy simulation and the updated iRT platform aiming to simplify workflows and boost precision. These technological advancements in radiotherapy considerably improve imaging accuracy and exactness, simplify workflows, and enhance personalization and analytics capabilities, thereby optimizing single-dose radiotherapy treatments for individual patients and increasing the efficiency, effectiveness, and accessibility of these services.
Who Are The Prominent Players Across The Single Molecule Real Time Sequencing Market?
Major companies operating in the single molecule real time sequencing market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Pacific Biosciences of California Inc., Oxford Nanopore Technologies Limited, Illumina Inc., BGI Genomics Co. Ltd., Novogene Corporation, New England Biolabs Inc., Zymo Research Corporation, GENEWIZ Inc., Dovetail Genomics LLC, Singular Genomics Systems Inc., Horizon Discovery Group plc, Asuragen Inc., LGC Limited, Tecan Group Ltd, 10x Genomics Inc.
Access The Complete Single Molecule Real Time Sequencing Market Report:
Which Region Accounts For The Highest Share Of The Single Molecule Real Time Sequencing Market?
North America was the largest region in the single molecule real time sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single molecule real time sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Single Molecule Real Time Sequencing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=20631&type=smp
Browse Through More Reports Similar to the Global Single Molecule Real Time Sequencing Market 2026, By The Business Research Company
Next Generation Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Next Generation Military Power Supply Global Market Report 2026
Next Generation Computing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/next-generation-computing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model